Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Éva Ajzner

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
EJIFCC|September 30, 2016
Adding Value in the Postanalytical PhaseÉva Ajzner
Clinical Biochemistry|May 28, 2017
Toward harmonization of interpretive commenting of common laboratory testsAttila Bezzegh, Ildikó Takács, Éva Ajzner
Orvosi Hetilap|December 5, 2017
[Laboratory aspects of novel oral anticoagulant treatment]Zsuzsanna Bereczky, Zsolt Oláh, Éva Ajzner, et al.
Ideggyogyaszati Szemle|August 9, 2021
[Encephalitis following COVID-19 disease]Lajos Varannai, Zsuzsa Magyar, Beatrix Baranyai, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 30, 2022
An international study on activated partial thromboplastin time prolongation. Part 1: Analytical resultsJosep Miquel Bauça, Éva Ajzner, Janne Cadamuro, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 2, 2022
An international study on activated partial thromboplastin time prolongation. Part 2: Interpretative commentingJosep Miquel Bauça, Éva Ajzner, Janne Cadamuro, et al.
Vaccines|April 23, 2022
Antibody and T Cell Responses against SARS-CoV-2 Elicited by the Third Dose of BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) Vaccines Using a Homologous or Heterologous Booster Vaccination StrategyZsolt Matula, Márton Gönczi, Gabriella Bekő, et al.
Geroscience|October 11, 2021
Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humansIstván Vályi-Nagy, Zsolt Matula, Márton Gönczi, et al.
Frontiers in Immunology|August 18, 2025
Impact of thromboplastin reagents on monitoring INR in a patient with triple-positive antiphospholipid syndrome: a case reportLóránt Varju, Zsuzsa Bagoly, Éva Ajzner, et al.
Clinical Chemistry and Laboratory Medicine|May 30, 2015
An international study of how laboratories handle and evaluate patient samples after detecting an unexpected APTT prolongationÉva Ajzner, Dunja Rogic, Piet Meijer, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
EJIFCC|September 30, 2016
Adding Value in the Postanalytical PhaseÉva Ajzner
Clinical Biochemistry|May 28, 2017
Toward harmonization of interpretive commenting of common laboratory testsAttila Bezzegh, Ildikó Takács, Éva Ajzner
Orvosi Hetilap|December 5, 2017
[Laboratory aspects of novel oral anticoagulant treatment]Zsuzsanna Bereczky, Zsolt Oláh, Éva Ajzner, et al.
Ideggyogyaszati Szemle|August 9, 2021
[Encephalitis following COVID-19 disease]Lajos Varannai, Zsuzsa Magyar, Beatrix Baranyai, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 30, 2022
An international study on activated partial thromboplastin time prolongation. Part 1: Analytical resultsJosep Miquel Bauça, Éva Ajzner, Janne Cadamuro, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 2, 2022
An international study on activated partial thromboplastin time prolongation. Part 2: Interpretative commentingJosep Miquel Bauça, Éva Ajzner, Janne Cadamuro, et al.
Vaccines|April 23, 2022
Antibody and T Cell Responses against SARS-CoV-2 Elicited by the Third Dose of BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) Vaccines Using a Homologous or Heterologous Booster Vaccination StrategyZsolt Matula, Márton Gönczi, Gabriella Bekő, et al.
Geroscience|October 11, 2021
Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humansIstván Vályi-Nagy, Zsolt Matula, Márton Gönczi, et al.
Frontiers in Immunology|August 18, 2025
Impact of thromboplastin reagents on monitoring INR in a patient with triple-positive antiphospholipid syndrome: a case reportLóránt Varju, Zsuzsa Bagoly, Éva Ajzner, et al.
Clinical Chemistry and Laboratory Medicine|May 30, 2015
An international study of how laboratories handle and evaluate patient samples after detecting an unexpected APTT prolongationÉva Ajzner, Dunja Rogic, Piet Meijer, et al.
Pageof 2